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Abstract. Tetrahydro-4H-(pyrrolo[3,4-d]isoxazol-3-yl)methanamine scaffold was designed as 
diamino derivative to stabilize parallel turn conformations. Its synthesis took advantage of a [1,3]-
dipolar cycloaddition reaction between the nitrile oxide derived from the inexpensive enantiopure L-
phenylalanine, and N-benzyl-3-pyrroline. Two diastereoisomers were formed whose distribution 
depends on the selected base. 3aR,6aS-Isomer is favoured in organic bases which formation is driven 
by p-interactions. On the other hand, the above interactions were significantly prevented using an 
inorganic base due to the chaotropic effect of the cation, decreasing the amount of the above isomer. 
Finally, we demonstrated that this isomer is able of stabilizing parallel turn conformations when 
inserted in short peptide sequences.  
 
Introduction 
The use of non-coded amino acids or scaffolds for the synthesis of peptidomimetics mimicking the 
natural structures opens the door to a huge number of different artificial shapes such as helixes, 
different kind of turns, and stabilized β-strand.1 Focusing on β-strand natural peptides, they can 
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assemble into either antiparallel or parallel β-sheets,2 very important motifs for the protein folding 
and fibril formations. Several proteins are characterized by parallel β-sheet motif ranging from 
amyloid3a,b,d,f to prion protein (PrPC)3c, leucine-rich repeat (LRR)-containing proteins,3h shikimate 
kinase (SK) involved in tubercolosys3g and many others.  
Strategies designed to stabilize this motif mostly consist in the use of an artificial scaffold that can be 
used to link two β-strands by N- or C-terminus.4 Other strategies are reported such as the formation 
of cyclic peptides,4a and the stabilization via disulfide cross-link between cysteins.5  
These strategies are particularly profitable not only to stabilize intermolecular interactions for bio-
molecular recognition, but also to improve metabolic stability necessary in the biological field.  
Our interest toward the preparation of non-coded amino acids6 and their use for peptidomimetic 
synthesis and their applications7 is well documented. In this respect, click reactions were used both 
to stabilize b-hairpin structures,8a and to prepare a new scaffold useful in the preparation of b-hairpin 
mimics targeting the Alzheimer disease.8b 
Here we focused on the design and synthesis of a new Δ2-isoxazoline scaffold, fused with a 
pyrrolidine ring, of general structure 3 to be used to stabilize parallel turn conformations (Scheme 1).  
 
 
Scheme 1. Retrosynthetic pathway to obtain isoxazoline-containing scaffold and peptidomimetics. 
 
This scaffold shows appealing features such as the presence of two amino groups, making it a good 
candidate for the above application. Furthermore, due to its calix conformational constraint, it could 
better orient the peptide arms, thus improving intra-strand H-bonds. The presence of oxygen/nitrogen 
atoms in the isoxazoline ring, as well as the aromatic moieties make this turn region appealing for 
possible intermolecular H-bonds and p-interactions, respectively, when it is used to build 
peptidomimetics targeting PPI interactions.  
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Isoxazoline derivatives are often prepared using, as key step, a [1,3]-dipolar cycloaddition reaction 
between nitrile oxides and dipolarophiles.9 The main drawback in using isolated nitrile oxides regards 
their instability.10 In fact, they easily rearrange to isocyanate, generally by heating, or dimerize giving 
furoxanes at room or lower temperatures. The formation of these side products affects the yield of 
the cycloaddition reaction, resulting in a difficult isolation and purification of the reaction products. 
For these reasons, nitrile oxides are usually generated in situ in the presence of a dipolarophile. They 
can be obtained in different ways according to Mukaiyama’s,11 Huisgen’s protocols,12 and Machetti-
De Sarlo reactions.13 Huisgen’s protocol consists in a basic dehydrohalogenation of a hydroximoyl 
halide, easily obtained from an aldoxime, giving the nitrile oxide. We envisaged in this procedure the 
best protocol to obtain an isoxazoline ring functionalized with a nitrogen containing chain. As shown 
in the retrosynthetic Scheme 1, chlorooxime 1 was selected as a chiral starting material to generate 
the corresponding nitrile oxide because it can be obtained from an inexpensive commercially 
available chiral amino acid.14 As dipolarophile, 3-pyrroline 2 was selected giving access to a second 
nitrogen atom in the final scaffold. Thanks to its symmetry, the formation of regioisomeric mixtures 
is avoided. A couple of diastereoisomeric isoxazolines could be obtained due to the presence of a 
stereocenter in the nitrile oxide.  
As reported in the literature,9c the cycloaddition of chiral nitrile oxides to achiral alkenes generally 
results in poor stereoselection. Considering the unfavourable chirality of our reagents (chiral nitrile 
oxide and achiral alkene) and also the low reactivity of the dienophile,15 our challenge has been the 
preparation of scaffold 3 in satisfying yields and with a control of the diastereoselection. To reach 
this target, we envisaged in the use of two aryl substituted reagents, able to stabilize the transition 
state through π interactions, the key step to drive the diastereoselection. As a result, the nitrile oxide 
derived from L-phenylalanine and the N-benzyl-3-pyrroline were used. Our hypothesis has also been 
supported by computational studies. 
Both diastereoisomers of 3 were used for the preparation of short peptides (Scheme 1) whose 
conformation was studied by NMR spectroscopy. We found that the 3aR,6aS-isomer is able to 
stabilize parallel turn conformations when combined with natural amino acids. 
 
Results and discussion 
Synthesis of scaffold 3. Chlorooxime 1, the precursor of nitrile oxide, was synthesized starting from 
the enantiopure cheap commercially available (L)-Phe. (Scheme S1, Supporting Information). Its 
synthesis, via oxime intermediate 7, was revisited due to a partial racemization of the precursor 
aldehyde 6. All the screened procedures and the corresponding HPLC are reported in the Supporting 
Information (Figure S1, Supporting Information).  
  
 4 
The cycloaddition reaction was performed by using N-benzyl-3-pyrroline (2) as dipolarophile. Two 
diastereoisomeric compounds could be expected, i.e. D2-isoxazoline derivatives 3a and 3b (Scheme 
2). To optimize the yield and to control the diastereoselection, several reaction conditions were tested 
and the overall results are reported in the Table 1.  
 
Scheme 2. Cycloaddition reaction between 1 and 2. 
 
 
Table 1. Reaction conditions tested for the cycloaddition reaction between 1 and 2 affording compounds 3. 
Entry Solvent 
(25 °C) 
Base Time (h) 3a:3b d.r.a 3a/3b, %b 
1c CHCl3 TEA 18  - 6% 
2d MeCN TEA  16  1:3 38% 
3e MeCN DABCO 16  1:2.5 24% 
4d AcOEt NaHCO3 17  1:2 32% 
5e MeCN NaHCO3 5  1:2 51% 
6f MeCN Li2CO3 20 1:1 50% 
7e MeCN/DMFg TEA 16  1:3 50% 
8e MeCN/DMFg DABCO 16 1:2.5 53% 
9e MeCN/NMPg TEA 16 1:2 29% 
10e MeCN/DMFg NaHCO3  4 - Traces 
11h MeCN/DMFg NaHCO3 16 1:2 31% 
12 MeCN/DMFg TEA (2 eq.) 
LiCl (2 eq.) 
16 1:1 14% 
aCalculated by 1H NMR analysis; bIsolated producs; c1:2:TEA in 1:1:1.2 ratio at reflux; d1:2:base in 2.2:1:2.2 ratio at 25 
°C, slowly addition of 1 (1 h); e1:2:base in 2:1:2 ratio at 25 °C and slowly addition of 1 (2 h); f 1:2:base in 2:1:1 ratio at 
25 °C and slowly addition of 1 (2 h); gMeCN/DMF (5:1); hThe reaction was performed as described in the note e) but at 
0°C. 
 
First, we performed the cycloaddition reaction using the standard conditions reported in the literature 
when nitrile oxide derived from amino acids were used.14b The reaction was performed using a 
mixture of 1 and 2 (1:1) in CHCl3 at reflux after which TEA (1.2 equiv.) was added as base to generate 
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the nitrile oxide (Table 1, entry 1). A mixture of 3a and 3b was obtained in very low yield. The 
temperature (from 0 to 25 °C) and the amount of TEA (2 equiv.) were changed, as well the base 
(1/2/DABCO, 1:1:2), but the reaction failed. 
MeCN was then tested instead of CHCl3 for its higher polarity. Operating at 25 °C and increasing 
both the amount of 1 and TEA (entry 2), a mixture of 3a and 3b (1:3 ratio) was obtained in 38% yield. 
Worse results were achieved when changing the addition order of the reagents, being the addition of 
the chloroxime the last one. Lower yield or trace amounts of compounds 3 were detected when 
changing the base (DABCO, entry 3; DIPEA or DBU, data not reported) and operating as reported 
above.  
Then we switched to inorganic bases. NaHCO3 was used both in AcOEt (entry 4) and MeCN (entry 
5). A dramatic decrease of the reaction time and an increase of yields (51%) but with a loss of 
diastereoselectivity (1:2) was found with MeCN. Similar results were achieved with Li2CO3 with a 
further decrease of the diastereoselection (entry 6). A phase-transfer catalysis protocol in 
heterogeneous conditions was also attempted using K2CO3 and tetrabutylammonium bromide as the 
catalyst in MeCN (1/2/Bu4NBr/K2CO3, 1:0.5:0.1:2) affording only trace amounts of compounds 3. 
Since 3b was the diastereoisomer of interest for the preparation of parallel sheets (see below), further 
efforts were done to improve its yield. Considering the beneficial result in terms of yield when the 
more polar MeCN was used, we tested a mixture of MeCN/DMF (5:1 ratio) and TEA as the base. 
The reaction was successful and compounds 3a/3b were obtained in the same ratio but with improved 
yield (50%, entry 7). Similar results were found with DABCO (entry 8) with a small decrease in 
diastereoselection. On the other hand, when NMP was tested as a co-solvent, a decrease of yield was 
found (entry 9).  
We also evaluated the use of NaHCO3 in MeCN/DMF at both 25 °C (entry 10) and at 0 °C (entry 11). 
The reaction failed in the first case and gave lower yields in the second one, maintaining the same 
diastereoisomeric ratio (compare entries 5 and 11). 
Overall, our results indicate that more polar solvents (MeCN/CHCl3; compare entries 1, 2 and 7) are 
beneficial to the reaction yields when a weak organic base (pKb 5-3) is used. The use of inorganic 
bases in MeCN heterogeneous conditions give good results too. On the other hand. in this case the 
higher is the polarity of the solvent the lower are the yields (compare entries 10, 11 with 5). This is 
probably due to the improved solubility of the base. As a result, the formation of nitrile oxide strongly 
increases that partially gave by-products because of the low reactivity of the dienophile.15b By taking 
these data together, it has to be concluded that the rate of the nitrile oxide generation from 1 is crucial 
to avoid side-reactions, in agreement to the reported results.15 It has to be pointed out that a 50% yield 
represents a rather good result, considering the sluggish reactivity of our dipolarophile. 
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Interestingly, we observed that the diastereoisomeric ratio is affected by the choice of the organic or 
inorganic base, moving from 1:3 ratio in favour of adduct 3b, to 1:1 ratio, respectively.  
To clarify the above results, computational studies were performed. First, diastereoiosmers 3a and 3b 
were evaluated by a conformational search at the molecular mechanics level. All the conformations 
found in the range of 2 kcal/mol (20 and 25 for 3a and 3b, respectively) were then selected for DFT 
optimization and energy evaluation at the CPCM-HCTC/6-311+G(d,p)//HCTH/6-31+G(d) level,16 
accordingly to a protocol previously adopted for similar studies, using MeCN as the solvent. The 
geometries of the most stable conformation for each compound is presented in supplementary Figure 
S9 (Supporting Information), while the energies obtained for all 3a and 3b conformations are reported 
in Tables S5 and S6 (Supporting Information), respectively. 
Since the observed diastereoselectivity is likely to be determined at the transition state level, the most 
stable conformations of 3a and 3b were used to generate the corresponding transition structures TS-
3a and TS-3b, that were successively optimized using the same scheme as above. Single point 
energies were then calculated at the HCTH/6-311+g(d,p) level, using the CPCM solvent model for 
MeCN. The optimized transition structures of TS-3a and TS-3b are shown in Figure 1. 
 
Figure 1. Optimized structures of TS-3a and TS-3b. Selected distances are reported in Angstrom. 
 
Although the enthalpy difference between the two transition states (TS) is quite low (0.2 kcal/mol), 
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TS-3b is favoured. Based on the Arrhenius equation (see Table S7 and Equation ES1 in Supporting 
Information), the predicted ratio for 3a and 3b is 28:72. This ratio is very close to that experimentally 
determined (1:3, when an organic base is used), confirming that the reaction is under kinetic control 
and that the chosen level of theory is correct. The analysis of the geometry of the two TSs shows that 
TS-3b can be stabilized by a T-shaped CH/π interaction between the two aromatic rings. In TS-3a, 
the phenyl-phenyl interaction is replaced by a CH/π interaction between the Boc moiety and the 
pyrroline benzyl group that, being mediated by hydrogens linked to a sp3 carbon is probably weaker, 
thus the slightly lower stabilization observed. 
Therefore, based on our computational results, we can hypothesize that when an organic base is used, 
π-interactions between the aryl moieties of pyrroline and nitrile oxide derivatives drive the 
diastereoselectivity. As a result, even if we are not in a favourable stereochemical environment (see 
introduction9c), the formation of 3b increases, supporting our strategy in selecting two aryl-
functionalized reagents to drive the diastereoselection. 
When using the inorganic base, the decrease in diastereoselection could be due to the presence of a 
metal cation able to disrupt the π-interactions, thus acting as “chaotropic agent”.17 Indeed, it has been 
reported that metal cations can destroy week interaction with a trend Li+ > Na+. In our case the 
distribution between 3a and 3b is confirmed (compare entries 5 and 6, Table 1). To further verify this 
hypothesis, we performed the cycloaddition reaction using TEA, in the presence of LiCl as the 
cationic donor (Table 1, entry 16). It was found that a decrease in the yields occurred together with a 
decrease in the diastereoselection (1:1 ratio instead of 1:3, found in absence of LiCl). This last result 
confirms that the stereochemical results might be driven by π-interactions, as suggested by the 
computational study. 
Even if diastereoisomers 3a and 3b were collected as a rather inseparable mixture, their purification 
on silica gel column chromatography allowed the isolation and characterization of a pure amount of 
diastereoisomer 3b. 1H NOESY analysis (CD3CN) of the major diastereoisomer 3b shows some 
significant spatial proximities (Figure 2A), allowing us to assign the 3aR,6aS-configuration to the 
new generated stereocenters with respect to the S configuration of the side chain.  
As a further confirmation, suitable needle-shape crystals of 9b, the debenzylated compound of 3b 
obtained as described in Scheme 3, were achieved (CDCl3/Et2O, 1:10). Their single-X-ray-crystal 
analysis confirmed the (3aR,6aS) absolute configuration of the isoxazoline derivative 9b and, 
indirectly, of 3b (Figure 2B). Crystal structure data of 9b was deposited at the Cambridge 
Crystallographic Data Centre and allocated the deposition number CCDC 1841009. 
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Figure 2. A) NOE signals of compound 3b. B) ORTEP plot of 9b at 293 K with atom numbering 
scheme; ellipsoids of non-H atoms are at 15% probability level.  
 
Peptidomimetic synthesis. Both diasteroisomers 3a and 3b were used for the preparation of 
peptidomimetic models (Scheme 3). Their orthogonal deprotection at nitrogen of the pyrrolidine ring 
was first studied. Since the isoxazoline nucleus is not stable to the catalytic reduction with H2/Pd, a 
“one-pot” debenzylation/acylation reaction was selected according to a known procedure.18 Starting 
from of a mixture of 3a and 3b and by using 2,2,2-trichloroethyl chloroformate (TrocCl; MeCN, 2 h, 
98%), diastereoisomers 8a and 8b were efficiently obtained and easily separated by flash 
chromatography. 
The nitrogen of pyrrolidine ring of compounds 8 was orthogonally deprotected with Zn powder in an 
aqueous solution of AcOH (90%) at 25 °C giving Boc-derivatives 9a (80%) and 9b (70%).  
Two small peptides models, i.e. 11a and 11b, were prepared to evaluate the ability of our scaffolds 
to stabilize a parallel turn conformation when inserted in a natural sequence. The dipeptide N-Ac-
Leu-Val-OH (10) was made to react with amines 9a and 9b. Compounds 11a (65%) and 11b (59%) 
were obtained in very good yield using the solution phase protocol and the classic coupling agents 
[EDC (1.1 equiv.), HOBT, (1.1 equiv.), DIEA (1.1 equiv.) in CH2Cl2]. 
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Scheme 3. Synthesis of peptides 11-15. Reaction conditions: i) TrocCl (1 eq.), MeCN, 25 °C, 2 h; ii) 
Zn, AcOH, 25 °C; iii) EDC (1.1 equiv.)/HOBT (1.1 equiv.)/DIEA (1.1 equiv.), CH2Cl2. 
 
NMR spectroscopy characterization of peptides. Peptides 11 were fully characterized by NMR 
(1H, 13C, HMBC, HSQC, NOESY; MeCN, 300 MHz; for details see Tables S1-S4 in Supporting 
Information).  
1H NMR analysis of compound 11b revealed the presence of two main isomers in 60:40 ratio. 
NOESY experiments showed that similar NOEs are present for the same proton in the two isomers 
proving an equilibrium between them. Well-distributed chemical shifts of amide protons were 
detected. Furthermore, 3JHN/CH are major than 8 Hz both for Val and Leu as well as for the residue 
linked to the isoxazoline ring that could be considered the equivalent of Phe. These data suggest that 
the peptide chain could assume a well-ordered conformation.  
The main observed NOEs for both isomers of compound 11b were reported in Figure 3. A medium 
NOE was detected between H4y and CHBn in both isomers (Figure S8A, Supporting Information) as 
well as a spatial proximity between CHLeu/NHVal (s; Figure 4). A week NHLeu/NHVal NOE (Figure 
S7B) was found for 11b due to the conformational freedom of Leu. Of relevance, intrastrand 
proximities were detected between the phenyl ring and MeVal (Figure 4) and between Boc and the 
alkyl chain of Leu.19 These NOEs support the idea that a parallel turn conformation could be induced 
by our scaffold. 
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Figure 3. NOEs (red lines; 300 MHz, 500 ms) and H-bond (dotted black lines) of peptide 11b and 
11’b.  
 
 
 
Figure 4. CH/NH NOEs regions (CD3CN, 20 mM, 300 MHz, 500 ms): black*, main isomer 11b; 
red°, minor isomer 11b’; blu, overlapped signals. 
 
The dD/dT analyses showed that NHBoc is involved in a H-bond (-4.5 ppb) for isomer 11b and NHLeu 
(-4 ppb) for isomer 11b’ (Figure 5). Since these isomers are in equilibrium, these values are consistent 
with a medium dD/dT value. Coalescence of NHBoc signal occurs at 313K and a completed 
coalescence for all NHs takes place at 323K. We hypothesize that NHBoc forms an H-bond with 
C=OLeu in rotamer 11b and NHLeu with C=OBoc in isomer 11b’. The formation of a H-bond between 
NHBoc and C=OVal was excluded because is not consistent with the detected NOEs (H4y/CHBn 
proximity). 
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Figure 5. Dd/DT NH values (273-323 K; 300 MHz) for conformers 11b and 11b’. 
 
A mixture of two conformers (about 1:1 ratio), with a minor amount of a third one, was detected in 
the 1H NMR spectrum of diastereoisomer 11a. Several signals are overlapped preventing the fine 
characterization of the main isomers. With respect to 11b, larger Dd/DT values were observed (Figure  
S4, Supporting Information). A complete coalescence for all NHs takes place at 313K. 
Several NOEs are present between CHVal with both protons H-4 and H-6 as well as between CHLeu 
with H-4x and H-6y (Figure S5, Supporting Information). Differently to 11b, intrastrand NOEs were 
not detected. Taken together these data suggest that a random conformation for this peptide is more 
likely.  
  
Conclusion 
In conclusion, the synthesis of two diastereoisomeric tetrahydro-4H-(pyrrolo[3,4-d]isoxazol-3-
yl)methanamine derivatives was performed using a [1,3]-dipolar cycloaddition reaction between the 
nitrile oxide derived from the cheap enantiopure L-phenylalanine and N-benzylpyrroline. 
Computational studies confirmed that p-interactions between the phenyl substituents of the reagents 
favour the formation of the 3aR,6aS-isomer 3b. NMR studies of model peptides containing the 
molecular scaffolds 3 proved that 3b, the main isomer obtained in the cycloaddition reaction, 
stabilizes a parallel turn conformation. Thus, 3b could be used as a profitable scaffold for the 
stabilization of parallel β-sheet secondary structures. 
 
 
Experimental 
General Information. Melting points were determined in a Stuart Scientific melting point apparatus 
in open capillary tubes and are certified. Chemicals were obtained from Sigma Aldrich and used 
without further purification. HPLC analyses were carried out on Jasco PU-980 pump equipped with 
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a UV–vis detector Jasco UV-975 (wavelength: 220 nm) and on a Kromasil 5-AmyCoat column (4.6 
mm i.d. × 250 mm, 5 µm, AkzoNobel). ESI mass spectra were recorded on an LCQESI MS were 
recorded on a LCQ Advantage spectrometer from Thermo Finningan and a LCQ Fleet spectrometer 
from Thermo Scientific. The NMR spectroscopic experiments were carried out on a Varian OXFORD 
300 MHz (300 and 75 MHz for 1H and 13C, respectively). Optical rotations were measured on a 
Perkin–Elmer 343 polarimeter at 20°C (concentration in g/100 mL). Chemical shifts δ are given in 
ppm relative to the CHCl3 internal standard, and the coupling constants J are reported in Hertz (Hz). 
t-Butyl (S)-(1-hydroxy-3-phenylpropan-2-yl)carbamate (5). Operating in a three-neck round-bottom 
flask, equipped with magnetic stirrer, thermometer, nitrogen inlet and dropping funnel, NaBH4 (400 
mg, 10.5 mmol) was suspended in THF (20 mL). The solution was cooled to 0°C and a solution of I2 
(1.5 g, 6 mmol) in THF (5 mL) was added very slowly under vigorous stirring. L-phenylalanine (4) 
(1 g, 6 mmol) was added in one portion and the reaction mixture was stirred at reflux for 16 h. After 
cooling at 25 °C, MeOH (13 mL) was added until discoloration and the stirring was continued for 
further 30 min. The solution was cooled to 0°C and TEA (1.67 mL, 12 mmol) was added dropwise. 
After 10 min., a solution of di-tert-butyl dicarbonate (1.4 g, 6.4 mmol) in THF (4 mL) was dropped. 
The reaction mixture was stirred for additional 20 h. The solvent was removed under reduced pressure 
and the crude reaction mixture was dissolved in ethyl acetate (15 mL). The organic layer was washed 
with saturated solution of NH4Cl (10 mL) and dried over Na2SO4. The solvent was removed under 
reduced pressure and the crude product was crystallized from hexane/AcOEt (12:1), affording 
compound 5 (1.5 g, 5.85 mmol, 97%) as a white solid. TLC: hexane/AcOEt, 7:3 (Rf: 0.18). Mp 92°C; 
[α] 20D: -28.5° (c 0.6 in CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.32-7.20 (m, 5H), 4.80 (br s, 1H), 
3.86 (br s, 1H), 3.66-3.63 (m, 1H), 3.55-3.52 (m, 1H), 2.83 (d, J 7 Hz, 2H), 2.08 (br s, 1H), 1.41 (s, 
9H) ppm; MS (ESI) m/z: Calcd for C14H21NO3 251.15; Found 274.40 [M+Na]+. The analytical and 
spectroscopical data are in agreement with the literature data.20 
t-Butyl (S)-(1-oxo-3-phenylpropan-2-yl)carbamate (6). Method A: Swern Oxidation. Operating in a 
three-neck round-bottom flask, equipped with magnetic stirrer, thermometer and nitrogen inlet, a 
solution of dry (COCl)2 (0.25 mL, 3 mmol) in dry CH2Cl2 (2.5 mL) was added and cooled to -78°C. 
A solution of dry DMSO (0.24 mL, 3.4 mmol) in CH2Cl2 (1.0 mL) was dropped over 5 min, and then 
the reaction was stirred for 15 min. A solution of 5 (500 mg, 2.0 mmol) in dry CH2Cl2 (2.5 mL) was 
dropped over 10 min. The reaction mixture was stirred for 30 min. and then a solution of dry TEA 
(1.12 mL, 8.0 mmol) was added dropwise over 10 min. The reaction was slowly heated to 25 °C and 
was stirred for 1 hour. The reaction mixture was diluted with CH2Cl2 (16 mL) and washed with 10% 
citric acid (15 mL), H2O (15 mL), a saturated solution of NaHCO3 (15 mL) and dried over Na2SO4. 
The solvent was removed under reduced pressure. The crude compound (493 mg, 1.98 mmol, 99%) 
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was immediately transformed into oxime 7 without further purifications (for HPLC analysis see 
Figures S1X and S1Y). Method B: Dess-Martin oxidation. Operating in a round-bottom flask, 
equipped with magnetic stirrer, Dess-Martin periodinane (551 mg, 1.3 mmol) was suspended in a 
mixture of CH2Cl2 (5 mL) and dioxane (3mL). A solution of alcohol 5 (300 mg, 1.2 mmol) in CH2Cl2 
(1 mL) was added dropwise over a period of 20 min. The reaction was stirred at 25°C for 20 min. 
When the reaction was complete, Et2O (2 mL) and sodium thiosulfate (0.5 g) dissolved in a saturated 
NaHCO3 solution (2 mL) were added. The reaction was stirred for further 5 min and then Et2O (2 
mL) was added. The layers were separated and the organic one was washed with a saturated solution 
NaHCO3 (2 x 4 mL), H2O (2 x 4 mL) and dried over Na2SO4. The solvent was removed under reduced 
pressure, affording 6 (237 mg, 0.95 mmol, 93%) as a pale-yellow oil. 1H NMR (300 MHz, CDCl3) δ 
9.64 (s, 1H), 7.37-7.28 (m, 3H), 7.20-7.17 (m, 2H), 5.04 (s, 1H), 4.44 (d, J 6.4 Hz, 1H), 3.13 (d, J 6.4 
Hz, 2 H), 1.45 (s, 9 H). 1H NMR data are in agreement with the reported data.21 The aldehyde was 
immediately transformed into oxime 7 without further purifications. 
t-Butyl (S)-(1-(hydroxyimino)-3-phenylpropan-2-yl)carbamate (7). Operating in a bottom flask, 
equipped with magnetic stirrer and thermometer, aldehyde 6 (500 mg, 2 mmol) was dissolved in THF 
(7.5 mL) at 0°C. NaHCO3 (102.5 mg, 1.22 mmol) and H2NOH·HCl (148 mg, 2.2 mmol) were added 
to the solution. The reaction mixture was heated to 25 °C and stirred overnight (TLC: hexane/AcOEt, 
7:3). After solvent evaporation, the residue was extracted with ethyl acetate (4 x 4.5 mL). The 
combined organic layers were washed with brine (4.5 mL), dried over Na2SO4 and concentrated in 
vacuo. Purification of the crude product by flash chromatography (hexane/AcOEt 8:2) afforded 7 
(385 mg, 83% as a white solid). After crystallization pure isomer E-7 was isolated. Mp 120.3 °C 
(hexane/AcOEt, 10:1); [α]20D + 28.3° (c 1 in CHCl3);22 1H NMR (300 MHz, CD3CN): δ 8.90 (s, 1H), 
7.48-7.12 (m, 5H), 6.67 (d, J 6.1 Hz, 1H), 5.44 (brs, 1H), 4.90 (m, 1H), 2.99 (dd, J 4.9, 13.7 Hz, 1H), 
2.81 (dd, J 9.3, 13.7, Hz 1H), 1.39 (s, 9H) ppm; MS (ESI) m/z: Calcd for C14H20N2O3 264.15; Found 
286.9 [M+Na]+. Z-7 (small amount isolated by chromatography): mp 118.5 °C (hexane/AcOEt, 15:1); 
1H NMR (300 MHz, CD3CN) δ 8.59 (s, 1H), 7.49-7.26 (m, 6H), 5.26 (br s, 1H), 4.40 (ddd, J 14.4, 
8.4, 6.0 Hz, 1H), 2.99 (dd, J 13.7, 6.3, Hz, 1H), 2.86 (dd, J 13.7, 8.24 Hz, 1H), 1.39 (s, 9H) ppm. 
N-t-Butoxycarbonyl [1-chloro-1-(hydroxyimino)-3-phenylpropan-2-yl)]carbamate (1). Operating in 
a bottom flask, equipped with magnetic stirrer and thermometer, oxime 7 (550 mg, 2.1 mmol) was 
suspended in CCl4 (20 mL) and N-chlorosuccinimide (278 mg, 2.1 mmol) was added portion wise 
over a period of 60 min at 0°C. The reaction mixture was refluxed overnight. The solution was cooled 
to 0°C and filtered to remove the succinimide (TLC: hexane/AcOEt, 7:3; Rf 0.45). The solvent was 
removed under reduced pressure, affording product 7 (601.2 mg, 97%) as yellow oil. 1H NMR (300 
MHz, CD3CN) δ 9.34 (s, 1H), 7.38-7.23 (m, 5H), 5.75 (br s, 1H), 4.63 (dd, J 15.1, 7.7 Hz, 1H), 3.07 
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(dd, J 13.8, 7.7 Hz, 1H), 2.94 (dd, J 13.7, 8.5 Hz, 1H), 1.39 (s, 9H) ppm;24 MS (ESI) m/z: Calcd for 
C14H19ClN2O3 298.11; Found 299.5 [M+H]+. 
t-Butyl 1-(5-benzyl-3a,5,6,6a-tetrahydro-4H-pyrrolo[3,4-d]isoxazol-3-yl)-2S-
phenylethyl)carbamate (3). Method A. Chloro-oxime 1 (200 mg, 0.67 mmol) was dissolved in MeCN 
(5 mL) and DMF (1 mL). Distilled N-benzyl-3-pyrroline (2) (106.7 mg, 0.13 mL, 0.67 mmol) was 
added in one portion at 25 °C, followed by the addition of TEA (67.9 mg, 0.67 mmol) or DABCO 
(75.1 mg, 0.67 mmol). The reaction mixture was stirred for 1 h. Afterwards, chloro-oxime 2 (200 mg, 
0.67 mmol) and TEA (67.9 mg, 0.67 mmol) or and DABCO (75.1 mg, 0.67 mmol) were added 
portionwise over 60 min. The reaction mixture was stirred for additional 16 h at 25 °C. The solvent 
was removed under reduced pressure. Purification of the crude product by flash chromatography 
(hexane/AcOEt 9:1) afforded the diastereoisomeric mixture 3a/3b (TEA: 1:3, 132 mg, 49%; 
DABCO: 1:2.5, 151.6 mg, 53%) as a white solid. The same reaction performed in the presence of 
LiCl (58.8 mg, 1.34 mmol) gave a 1:1 mixture of 3a/3b (39.15 mg, 0.09 mmol, 14%). Method B. 
Chloro-oxime 1 (100 mg, 0.33 mmol) was dissolved in MeCN (3 mL). Distilled N-benzyl-3-pyrroline 
(2) (66.9 mg, 79.9 µL, 0.42 mmol) was added in one portion at 25 °C. NaHCO3 (26.9 mg, 0.33 mmol) 
or Li2CO3 (12.2 mg, 0.165 mmol) was added and the reaction mixture was stirred for 1 h. Chloro-
oxime 1 (152.04 mg, 0.51 mmol) and NaHCO3 (42.85 mg, 0.51 mmol) or (12.2 mg, 0.165 mmol) 
were subsequently added portionwise over 60 min. The reaction mixture was stirred for additional 4 
h at 25 °C. The solvent was removed under reduced pressure. Purification of the crude product by 
flash chromatography (hexane/AcOEt 9:1) afforded the diastereoisomeric mixture 3a/3b (NaHCO3  
1:2, 90 mg, 51%; Li2CO3 1:1, 66.55 mg, 48%) as a white solid. 
3aS,6aR 3a: mixture with 3b. 1H NMR (300 MHz, CD3CN) main signal: δ 4.70-4.60 (m, 1H) ppm; 
13C NMR (75 MHz, CD3CN) δ 159.2, 155.3, 138.8, 137.7, 129.4, 128.5, 128.3, 128.2, 126.9, 126.5, 
84.3, 78.8, 61.7, 58.4, 56.2, 53.5, 49.7, 38.7, 27.5 ppm.  
3aR,6aS-3b. TLC: hexane/AcOEt, 1:1; Rf 0.57. M.p. 99.3 °C; IR (NaCl) nmax 3374, 1712 cm-1; 1H 
NMR (300 MHz, CD3CN) δ 7.42-7.13 (m, 10H), 5.53 (d, J 8.8 Hz, 1H), 5.01 (dd, J 9.4, 4.6 Hz, 1H), 
4.53 (dd, J 14.1, 9.9 Hz, 1H), 3.83-3.69 (m, 1H), 3.55 (dd, J 22.4, 13.3 Hz, 2H); 3.25 (dd, J 14.2, 5.2 
Hz, 1H), 3.06 (d, J 9.6 Hz, 2H), 2.94 (dd, J 13.9, 9.7 Hz 1H), 2.36 (dd, J 11.0, 4.8 Hz, 1H), 2.27 (dd, 
J 10.0, 7.1 Hz, 1H), 1.40 (s, 9H) ppm; 13C NMR (75 MHz, CD3CN) δ 159.4, 138.9, 132.4, 129.3, 
128.5, 128.4, 128.3, 128.2, 127.0, 126.6, 126.3, 83.9, 61.9, 58.3, 56.0, 53.0, 48.8, 37.7 ppm; Anal. 
Calcd for C25H31N3O3: C, 71.23; H, 7.41; N, 9.97. Found: C, 71.06; H, 7.65; N, 9.80; MS (ESI) m/z: 
Calcd for C25H31N3O3 421.24; Found 422.24 [M+H]+; 444.26 [M+Na]+. 
2,2,2-Trichloroethyl 3-(2S-1-tert-butoxycarbonylamino-2-phenylethyl)-6,6a-dihydro-3aH-
pyrrolo[3,4-d]isoxazole-5(4H)-carboxylate (8). A mixture of 3a/3b (1:3 ratio; 50 mg, 0.12 mmol) 
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was dissolved in MeCN (2 mL) under stirring. 2,2,2-Trichloroethylchloroformate (29.7 mg, 19.3 µL, 
0.14 mmol) was added dropwise to the solution at 25 °C. The reaction mixture was stirred for 2 h. 
The solvent was removed under reduced pressure. Purification of the crude mixture by flash 
chromatography (hexane/AcOEt, 3:1) afforded the products 8a (19.7 mg, 0.04 mmol, 32.5%) and 8b 
(39.5 mg, 0.08 mmol, 65%) as white solids.  
3aS,6aR-8a: TLC: hexane/AcOEt, 7:3; Rf 0.23. Mp 125.5 °C; [α]20D: - 68.5 (c 1, MeOH); IR (NaCl) 
nmax  3355, 3061, 1717, 1690 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.36-7.23 (m, 5H), 5.13 (brs, 2H), 
4.76-4.66 (m, 3H), 3.98 (brs, 1H), 3.85 (brs, 1H), 3.64 (brs, 1H), 3.47-3.42 (m, 2H), 3.22-3.05 (m, 
2H), 1.43 (s, 9H) ppm; 13C NMR (75 MHz, CDCl3) δ 159.7, 155.0, 152.5, 136.4, 129.2, 128.7, 127.1, 
110.0, 85.0, 80.2, 75.0, 53.4, 52.9, 49.8, 49.2, 48.4, 40.1 ppm; Anal. Calcd for C21H26Cl3N3O5: C, 
49.77; H, 5.17; N, 8.29. Found: C, 49.61; H, 5.30; N, 8.10; MS (ESI) m/z: Calcd for C21H26Cl3N3O5 
505.9; Found 528.62 [M+Na]+. 
3aR,6aS-8b: TLC: hexane/AcOEt 7:3; Rf 0.19. M.p. 104.1 °C; [α]20D: + 31 (c 1, MeOH); IR (NaCl) 
nmax 3376, 3065, 1724, 1684 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.34-7.23 (m, 5H), 5.22-5.17 (m, 
1H), 4.76 - 4.66 (m, 4H), 3.96-3.77 (m, 3 H), 3.67-3.54 (m, 2H), 3.44-3.32 (m, 1H), 3.04-3.11 (m, 
1H), 1.38 (s, 1H) ppm; 13C NMR (75 MHz, CDCl3) 159.5, 155.2, 152.4, 136.8, 129.4, 128.6, 126.9, 
95.4, 84.4, 80.3, 75.0, 53.7,52.5, 48.6, 48.3, 38.5, 28.2 ppm; Anal. Calcd for C21H26Cl3N3O5: C, 49.77; 
H, 5.17; N, 8.29. Found: C, 49.68; H, 5.25; N, 8.15; MS (ESI) m/z: Calcd for C21H26Cl3N3O5 505.9; 
Found 528.48 [M+Na]+. 
t-Butyl (2S)-phenyl-1-(4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]isoxazol-3-yl)ethyl)carbamate (9). 
Compound 8 (40 mg, 0.08 mmol) was dissolved in an aqueous solution of AcOH (90%, 0.4 mL). Zn 
(80 mg, 2.6 mmol) was added at 0 °C and the reaction was left under stirring at 25 °C for 2 h (TLC: 
CH2Cl2/MeOH 40:1; Rf  0.12). Zinc was filtered and AcOH was removed under vacuum. The crude 
mixture was dissolved in AcOEt (4 mL) and the white solid was filtered. The mother liquor was 
extracted with NaHCO3 (2 x 4 mL) then dried over Na2SO4 and concentrated in vacuum. The crude 
was purified by flash chromatography (CH2Cl2/MeOH; 40:1) affording pure compound 9 as white 
foam (9a: 21 mg, 80%; 9b: 18.6 mg, 0.056 mmol, 70% yield). 
3aS,6aR-9a: [α]20D: -4 (c 1, MeOH); IR (NaCl) nmax 3358, 1682 cm-1;  1H NMR (300 MHz, CDCl3): 
δ 7.35-7.22 (m, 5H), 5.27-5.24 (m, 1H), 5.11-5.09 (m, 1H), 4.70-4.63 (m, 1H), 3.43 – 3.30 (m, 3H), 
3.31-3.09 (m, 3H), 3.07-2.82 (m, 2H), 1.42 (s, 9H) ppm; 13C NMR (75 MHz, CDCl3): 159.4, 155.2, 
136.4, 129.3, 128.7, 127.0, 86.7, 80.1, 56.2, 55.9, 51.3, 49.7, 40.2, 28.3 ppm; Anal. Calcd for 
C18H25N3O3: C, 65.23; H, 7.60; N, 12.68. Found: C, 65.00; H, 7.83; N, 12.47; MS (ESI) m/z: Calcd 
for C18H25N3O3 331.19; Found 332.2 [M+H]+. 
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3aR,6aS-9b: [α]20D: +12 (c 1, MeOH); IR (NaCl) nmax 3355, 1687 cm-1; 1H NMR (300 MHz, CDCl3) 
δ 7.20-7.40 (m, 5H), 5.10-5.20 (m, 1H), 4.87-4.45 (m, 2H), 3.63 (m, 3H), 3.40-3.21 (m, 2H), 3.00-
3.15 (m, 1H), 2.6- 2.8 (m, 2H), 2.0-1.8 (m, 2H), 1.2 (s, 9H) ppm; 13C NMR (75 MHz, CDCl3) δ 158.9, 
155.2, 137.1, 129.3, 127.0, 126.6, 87.1, 80.3, 56.7, 55.9, 51.5, 49.1, 39.3, 28.2 ppm; Anal. Calcd 
C18H25N3O3: C, 65.23; H, 7.60; N, 12.68. Found: C, 65.04; H, 7.79; N, 12.52; MS (ESI) m/z: Calcd 
for C18H25N3O3: 331.19; Found 332.18 [M+H]+. 
General Procedure for Peptide Synthesis. Dipeptide Ac-N-Leu-Val-OH (10) (46.4 mg, 0.17 mmol) 
was dissolved in CH2Cl2 (3 mL) and CH2Cl2 (1 mL)/DMF (0.2 mL), respectively. The solution was 
cooled to 0 °C under stirring. HOBt (25.6 mg, 0.19 mmol) and EDC (36.8 mg, 0.19 mmol) were 
added. After 1 h, compound 9 (56.3 mg, 0.17 mmol) in CH2Cl2 (1 mL) was dropped, followed by the 
addition of DIEA (22 mg, 29 µL, 0.17 mmol). The reaction mixture was stirred for 24 h and then it 
was washed with a aqueous solution of KHSO4 (5%, 5 mL), a saturated solution of NaHCO3 (5 mL) 
and brine (5 mL). After drying over Na2SO4, the solvent was removed under reduced pressure. 
Purification of the crude mixture by flash chromatography (CH2Cl2/MeOH; 40:1) afforded compound 
11 (11a: 64.4 mg, 65%; 11b: 59.2 mg, 0.10 mmol, 59%) as a white solid.  
11a: TLC: CH2Cl2/MeOH, 40:1; Rf  0.20. [α]20D: -85 (c 0.3, MeOH); IR (NaCl) nmax 3437, 3305, 
1709, 1635 cm-1; Anal. Calcd C31H47N5O6 63.57; H, 8.09; N, 11.96; Found: 63.31; H, 8.40; N, 11.78; 
MS (ESI): m/z calcd for C31H47N5O6: 585.36; found: m/z 586.58 [M+H]+. For NMR data see Tables 
S1 and S2. 
11b: TLC: CH2Cl2/MeOH, 40:1; Rf  0.20. Rf  0.20. [α]20D: +25 (c 0.3, MeOH). IR (NaCl) nmax 3298, 
1699,1637 cm-1; Anal. Calcd C31H47N5O6 63.57; H, 8.09; N, 11.96; Found: 63.37; H, 8.38; N, 11.80; 
MS (ESI): m/z calcd for C31H47N5O6: 585.36; found: m/z 586.36 [M+H]+. For NMR data see Tables 
S3 and S4. 
Computational Methods. After designing the molecular structures using MOE software,25 compounds 
3a and 3b were submitted to a conformational search via Low Mode MD simulation, implemented in 
MOE, setting a Rejection Limit of 100, an Iteration Limit of 100000 and a MM Iteration Limit of 
1000. 
MMFF94x was used as the force field, while the Born solvent model with the dielectric constant of 
acetonitrile (e 37.5) was used to include solvation effects. For compound 3a, 203 different 
conformations were obtained in an energy range of 7 kcal/mol; 240 conformations were instead 
obtained for the compound 3b, in the same energy range. For each diastereoisomer all the 
conformations that were within 2 kcal/mol from the more stable one (20 conformations for 3a, 25 for 
3b) were subjected to a geometry optimization at the DFT level of theory, using the HCTH functional 
and the 6-31+G(d) basis set. Indeed, this protocol was successfully used in previous studies on [1,3]-
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dipolar cycloadditions where π-interactions resulted relevant in determining the regiochemical 
outcome of the reaction.14 A vibrational analysis was then performed on the optimized geometries 
and to calculate the zero point and thermochemical corrections to the electronic energies (1 atm, 
298.15 K) and no imaginary frequencies were observed. Single point energies were then computed at 
the HCTH/6-311+g(d,p) level, using CPCM solvent model for MeCN.26 The most stable 
conformation of 3a and 3b was used to generate a starting guess for the corresponding transition 
states (TS-3a and TS-3b, respectively), that were treated with the same protocol described above. 
The vibrational analysis, performed on the optimized geometries at the same level of theory, 
confirmed the presence of a single imaginary frequency (-362.52 and -357.85 cm-1 for TS-3a and TS-
3b, respectively) corresponding to the stretching of the forming C-C and C-O bonds. All quantum 
mechanical calculations were performed using the Gaussian09 package.27  
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